Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern cooperative oncology group data.
about
Lung cancer symptoms and pulse oximetry in the prognostic assessment of patients with lung cancer.Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: A meta-analysisA comprehensive review of nongenetic prognostic and predictive factors influencing the heterogeneity of outcomes in advanced non-small-cell lung cancerPrognostic models to predict survival in non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin with or without bevacizumabA laboratory prognostic index model for patients with advanced non-small cell lung cancerReporting methods in studies developing prognostic models in cancer: a review.Modeling the overall survival of patients with advanced-stage non-small cell lung cancer using data of routine laboratory tests.Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trialsIdentification of candidate molecular markers predicting chemotherapy resistance in non-small cell lung cancer.Reporting performance of prognostic models in cancer: a review.The impact of de novo liver metastasis on clinical outcome in patients with advanced non-small-cell lung cancer.Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer.Prospective study on the incidence of bone metastasis (BM) and skeletal-related events (SREs) in patients (pts) with stage IIIB and IV lung cancer-CSP-HOR 13.Smoking and prognostic factors in an observational setting in patients with advanced non-small cell lung carcinomaSpecific organ metastases and survival in metastatic non-small-cell lung cancer.mRNA expression levels and genetic status of genes involved in the EGFR and NF-κB pathways in metastatic non-small-cell lung cancer patients.The role of gene expression profiling in early-stage non-small cell lung cancer.Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasisDistribution and prognosis of uncommon metastases from non-small cell lung cancerMachine Learning methods for Quantitative Radiomic Biomarkers.Proteomic profiling identifies pathways dysregulated in non-small cell lung cancer and an inverse association of AMPK and adhesion pathways with recurrence.A new scoring system for predicting survival in patients with non-small cell lung cancerImpact of age and comorbidity on non-small-cell lung cancer treatment in older veterans.Tissue platinum concentration and tumor response in non-small-cell lung cancerRefining Prognosis in Lung Cancer: A Report on the Quality and Relevance of Clinical Prognostic Tools.Chemotherapy and prognosis in advanced thymic carcinoma patients.Surgical Treatment of Extrapulmonary Oligometastatic Non-small Cell Lung Cancer.γ-H2AX expression detected by immunohistochemistry correlates with prognosis in early operable non-small cell lung cancer.A Prognostic Model to Predict Mortality among Non-Small-Cell Lung Cancer Patients in the U.S. Military Health SystemCircadian function in patients with advanced non-small-cell lung cancer.Sunlight may increase the FDG uptake value in primary tumors of patients with non-small cell lung cancer.Prediagnosis soy food consumption and lung cancer survival in womenSex as an independent prognostic factor in a population-based non-small cell lung cancer cohort.Validation of a prognostic nomogram in patients undergoing resection for pancreatic ductal adenocarcinoma in a UK tertiary referral centre.Prognostic value of patient-reported symptom interference in patients with late-stage lung cancerGermline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapyEvaluation of peri-operative chemotherapy using a prognostic nomogram for survival after resection of colorectal liver metastases.Combination chemotherapy of gemcitabine and vinorelbine for pretreated non-small-cell lung cancer: a retrospective study.Factors associated with early progression of non-small-cell lung cancer treated by epidermal growth factor receptor tyrosine-kinase inhibitors.Circadian clock manipulation for cancer prevention and control and the relief of cancer symptoms.
P2860
Q24813083-38884438-3355-4833-A387-A7B09964B787Q26801799-AFA129B0-C1AD-4822-95D5-57E08784213CQ26865662-62D62196-9E97-42DF-8B18-7F2408064B3EQ28388270-A57D6484-E628-4E53-8398-A56BC6D57175Q28542513-90FCFAD9-D997-4AC8-A7A3-53E105F36C4BQ30494142-F1E48F70-C640-4A4C-8000-C5B59B262870Q30827122-2AA14539-C240-4F7D-8FC5-A8B6FC2C8AE7Q33436415-A3009443-2DBB-48AE-8BB9-7029F91B9820Q33546556-4CF95DE3-9A40-4328-9ADE-FB35FEA15FD7Q33547696-904ECDB8-01CA-44B0-888F-8D770187EA50Q33773098-19DC8809-B34A-4F4B-AC98-5EE432DC3365Q33875938-D751E2CC-98F5-41B2-83E8-2DDFEB9A5089Q34041808-9D78FB64-DCE5-4FBE-9613-73192CA3A5ACQ34487100-CEC5D70D-E7CB-482D-A7E4-95BA601CB903Q34607284-1DD7DF24-EDC5-47A3-92EF-44CA92F4D454Q35471961-F05BB966-85B3-4DAE-B77A-29A8B177A74FQ35667675-65EDC760-C74F-4487-859C-E1D4828FA49EQ35927299-4E560DBB-5E0A-4BF1-864F-A75C7D9ED9CAQ35934768-A90C7E8F-D456-4B5D-B54F-9AC1C3588693Q35960448-B0CF1733-8006-48D2-8515-F3ABA011283EQ36030339-62EE201D-40DA-4168-B572-25C8E45A4E2FQ36051766-C423C634-8A60-43AE-A2A2-78F9640E5175Q36058277-A676D474-E65A-4EF1-BA64-572AEF088445Q36222930-324820E0-DA56-444B-AD1D-D56DAB9951C8Q36258014-3CF0A3FE-97A2-4A0E-AD28-80FFBF5EC979Q36364682-09E5C8CA-C3A1-459D-B42B-5927A1498632Q36408553-582AB121-5DCE-43C5-81AE-A31336EEDBF4Q36409165-3B4650BE-F1B5-4497-96CB-210E05DC1318Q36414611-43BF3860-C937-4E72-895E-25EAE5C82BB2Q36614977-CE7CD145-7BC6-429E-855F-DFE6972D78FCQ36621221-5D4BA521-C130-4E5B-9329-507B5AB36397Q36763839-1359166C-9867-4037-A11A-E71AE548CDB6Q36772978-88D92701-65B9-41F7-9856-4919E87FEC69Q37002603-6A3AC39A-343F-478D-BFCA-3D6282315B00Q37048771-48FF53E6-F396-4A44-894F-E17F1978E71BQ37150706-ADC4C29E-4D0B-4A90-A451-9B5C024A9210Q37449388-91D40A31-C774-4EB5-A59E-153E5E679D09Q37566846-2609FC85-B3B8-4385-8CCF-B2635E037F9EQ37595242-D10E9186-D6FC-4D4E-838E-9DEE0ED50FF6Q37635574-4422A07A-85EC-4290-9EC4-86682D3D3EF6
P2860
Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern cooperative oncology group data.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Clinical model to predict surv ...... operative oncology group data.
@ast
Clinical model to predict surv ...... operative oncology group data.
@en
type
label
Clinical model to predict surv ...... operative oncology group data.
@ast
Clinical model to predict surv ...... operative oncology group data.
@en
prefLabel
Clinical model to predict surv ...... operative oncology group data.
@ast
Clinical model to predict surv ...... operative oncology group data.
@en
P2093
P356
P1476
Clinical model to predict surv ...... operative oncology group data.
@en
P2093
David H Johnson
Joan H Schiller
Philip Bonomi
Ronghui Xu
Tien Hoang
P304
P356
10.1200/JCO.2005.04.177
P407
P577
2005-01-01T00:00:00Z